Amgen Inc (NASDAQ: AMGN)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $437.23
-
Support level$392.17
-
Resistance levelN/A
-
Beta0.4
-
RSI (14-day)61.6
- AMGN is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- With a 56.1 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $271.18 | $444.12 | 96.8% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $358.45 | $397.06 | $431.44 | $438.80 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.3%
-
In the next month13.6%
-
In the next year52.8%
| Period | Value |
|---|---|
| Historical (5 year) | 24.2% |
| Last month | 26.2% |
| Current estimate | 23.1% |
| Next month forecast | 24.0% |